Agenus and dr. steven o'day to participate in panels at the virtual sitc 2020 immuno-oncology event hosted by b. riley

Lexington, mass., nov. 12, 2020 (globe newswire) -- agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that dr. steven o'day, executive director of the john wayne cancer institute, dr. jennifer buell, president and coo of agenus, and patrick jordan, coo of agentus therapeutics, will participate in panel discussions at the virtual sitc 2020 immuno-oncology event hosted by b. riley.
AGEN Ratings Summary
AGEN Quant Ranking